StockNews.com Begins Coverage on Sorrento Therapeutics (NASDAQ:SRNE)
StockNews.com assumed coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a research note released on Sunday. The firm issued a hold rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Price Performance Sorrento Therapeutics stock opened at $0.00 on Friday. Sorrento Therapeutics has a one year low of $0.00 and a one year […]
StockNews.com assumed coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a research note released on Sunday. The firm issued a hold rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Price Performance Sorrento Therapeutics stock opened at $0.00 on Friday. Sorrento Therapeutics has a one year low of $0.00 and a one year […]
